Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study
Development of an Inclusive Risk Prognostic Index for Newly Diagnosed Multiple Myeloma
Evaluation of Functional and Cytogenetic High-Risk Multiple Myeloma Using Real-World Data
REALM (OP-RW001): Comparing the Characteristics and Clinical Outcomes of Patients with Relapsed/Refractory Multiple Myeloma in the Real World to Patients Receiving Melflufen in the Horizon Study
Treatment Patterns and Outcomes of Patients with Double-Class Refractory or Triple-Class Refractory Multiple Myeloma: A Retrospective US Electronic Health Record Database Study
P-119: Evaluation of real-world frontline treatment for multiple myeloma by race
MM-123: Real-World Study of Treatment Patterns in Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM) in the US
KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma
Associations Between Amplification (1q) and Prior Cancer in a Real-World De Novo Myeloma Cohort
Prevalence and Survival Impact of Self-Reported Symptom and Psychological Distress Among Patients With Multiple Myeloma
